Global GI Stool Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global GI Stool Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Product Type (Instruments, and Reagents), Test Type (Occult Blood Test, Ova and Parasites Test, Bacteria Test, Fecal Biomarkers Test, and Other Test Types), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global GI Stool Testing Market was valued at USD 553.1 million in 2023 and is expected to reach USD 936.2 million by 2031 while growing at a CAGR of 6.8% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global GI stool testing market growth. Gastrointestinal (GI) stool testing, also referred to as stool analysis or stool culture, entails examining stool samples to assess gastrointestinal tract health and diagnose a range of gastrointestinal disorders or infections by analyzing stool composition, including microorganisms, blood, parasites, and other substances.
The rising incidence of GI disorders like IBD, IBS, celiac disease, and colorectal cancer, along with increased awareness and screening programs, propel the growth of the GI stool testing market. Yet, cost limitations and interference from diet and medication may hinder its expansion.
Furthermore, the global GI stool testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Product Type Analysis
The Global GI Stool Testing Market is segmented among Instruments, and Reagents, based on Product Type. In 2023, Reagents accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Test Type Analysis
The Global GI Stool Testing Market is segmented among Occult Blood Tests, Ova and Parasites Tests, Bacteria Tests, Fecal Biomarkers Tests, and Other Test Types, based on Test Type. In 2023, Occult Blood Tests accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global GI Stool Testing Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), bioMerieux SA, Cardinal Health, Cenogenics Corporation, CTK Biotech Inc., Genova Diagnostics, Epitope Diagnostics Inc., ScheBo Biotech AG, and Meridian Bioscience Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global GI Stool Testing Market Dynamics
Drivers
Restraints
Opportunity
4. Global GI Stool Testing Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global GI Stool Testing Market Segmentation, By Product Type
Global GI Stool Testing Market Share Analysis, By Product Type
Global GI Stool Testing Market Growth Analysis, By Product Type
Global GI Stool Testing Market Trends, By Product Type
o Instruments
o Reagents
6. Global GI Stool Testing Market Segmentation, By Test Type
Global GI Stool Testing Market Share Analysis, By Test Type
Global GI Stool Testing Market Growth Analysis, By Test Type
Global GI Stool Testing Market Trends, By Test Type
o Occult Blood Test
o Ova and Parasites Test
o Bacteria Test
o Fecal Biomarkers Test
o Other Test Types
7. Global GI Stool Testing Market Segmentation, By Region
Global GI Stool Testing Market Share Analysis, By Region
Global GI Stool Testing Market Growth Analysis, By Region
Global GI Stool Testing Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
8. Competitive Landscape
Abbott Laboratories*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Danaher Corporation (Beckman Coulter, Inc.)
bioMerieux SA
Cardinal Health
Cenogenics Corporation
CTK Biotech Inc.
Genova Diagnostics
Epitope Diagnostics Inc.
ScheBo Biotech AG
Meridian Bioscience Inc.
*Similar analysis will be provided for each company listed above.
